labetalol has been researched along with Muscular Diseases in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
Excerpt | Relevance | Reference |
---|---|---|
"Labetalol has been successful in treating hypertension, and few side effects have been reported, although there have been cases of muscle pain during treatment." | 3.66 | Labetalol-induced toxic myopathy. ( Kissin, E; Rosenthal, T; Sarova, I; Teicher, A, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Teicher, A | 1 |
Rosenthal, T | 1 |
Kissin, E | 1 |
Sarova, I | 1 |
1 other study available for labetalol and Muscular Diseases
Article | Year |
---|---|
Labetalol-induced toxic myopathy.
Topics: Adult; Creatine Kinase; Ethanolamines; Fructose-Bisphosphate Aldolase; Humans; Hypertension; L-Lacta | 1981 |